Jeffrey Leiden is the chairman, president and CEO of Vertex Pharmaceuticals. $0 was received as options,
Using that dataset, the median figure for the group was $177,560, a rough estimate of what a typical worker in the biotech and pharma industry might make. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov and entering the company's name and then looking in the first column for an entry of "Form DEF 14A" (or any similar code). $0 came from other types of compensation. Coronavirus Tips – Working and Protection. Dr. Jeffrey Leiden is the Executive Chairman of Vertex Pharmaceuticals. The information shown here is a reporting of information included in the company's proxy statement. Jeff Leiden is definitely looking at the long term. Salaries posted anonymously by Jefferies employees. A proxy statement (or "proxy") is a form that every publicly traded U.S. company is required to file with the U.S. Securities & Exchange Commission (SEC) within 120 days after the end of its fiscal year. Sign Up. Fewer companies, 112, reported median employee pay. $32,973,947 Jeff Immelt Chairman and CEO, General Electric $110,000 Senior Financial Analyst Bank of America $83,200 Niraj Shah CEO, co-chairman, and cofounder, Wayfair $157,000 Senior Manager New Balance $1,338,110 Stephen Kaufer President and CEO, TripAdvisor $90,000 Tax Supervisor (CPA) John Hancock $220,000 Region Sales Manager Johnson & Johnson $20,377,815 Thomas Kennedy Chairman and CEO, Raythe… Change in Pension Value and Nonqualified Deferred Compensation Earnings. Vertex Pharmaceuticals Incorporated (VRTX) Boston, MA. Jeffrey Leiden VRTX stock SEC Form 4 insiders trading. Also, proxies must disclose specific detailed information regarding the pay practices for certain executives. Option Awards: Compensation paid in the form of company equity that is structured as stock options. ... BASE SALARY CASH BONUS PERKS/ OTHER CASH … Rankings In 2014 , Jeffrey M. Leiden's compensation ranked 34th out of 13,032 executives tracked by ExecPay. Coronavirus Tips – Working and Protection. Of this total $1,300,000 was received as a salary, $3,510,000 was received as a bonus, $4,572,039 was received in stock options, $9,334,681 was awarded as stock and $73,265 came from other types of compensation. For those interested in conducting a detailed compensation analysis, we recommend that you review the entire proxy statement. Thorough reviews have been conducted to assure this data accurately reflects disclosures. The average employee at Vertex Pharmaceuticals earns a yearly salary of $95,721 per year, but different jobs can earn drastically different salaries. Of this total
For those interested in conducting a detailed compensation analysis, we recommend that you review the entire proxy statement. A free inside look at Jefferies salary trends based on 976 salaries wages for 282 jobs at Jefferies. VERTEX PHARMACEUTICALS INC / MA annual reports of executive compensation and pay are most commonly found in the Def 14a documents. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov and entering the company's name and then looking in the first column for an entry of "Form DEF 14A" (or any similar code). The median employee pay at Vertex is $211,511 for a ratio of 81 to 1. Rankings In 2011 , Jeffrey M. Leiden's compensation ranked 318th out of 10,747 executives tracked by ExecPay. Leiden’s package included a $1.3 million base salary, a $2.2 million cash bonus and $13.9 million in equity awards, a big decline from 2015 stock and option awards together valued at … All Other Compensation: Compensation that is paid in the form of perquisites, such as expense reimbursement. Job Title. Jeffrey M. Leiden, who assumed the top job at Vertex in late 2011, received a salary and cash bonus of about $4.1 million last year. You may also find the annual proxy statement by going directly to the company's website. As Executive Chairman (CEO and President) at VERTEX PHARMACEUTICALS INC / MA, Jeffrey M. Leiden made $18,789,985 in total compensation. To get a better sense of the salaries at The Vertex Companies, other roles such as cashier and customer service agent can be considered as well. This information is according to proxy statements filed for the 2019 fiscal year. Leiden was also paid $1.1 million in salary, $3 million in a cash bonus and $19.9 million in stock awards last year, according to the filing. He was initially appointed to the board of directors of the company in 2009 and was CEO and president from February 2012 to March 2020.. As a member of Board of Directors at QUEST DIAGNOSTICS INC, Jeffrey M. Leiden made $280,984 in total compensation. Jeffrey M. Leiden, Vertex $36.6 million. As Executive Chairman (CEO and President) at VERTEX PHARMACEUTICALS INC / MA, Jeffrey M. Leiden made $18,789,985 in total compensation. Your salary and benefits. Jeffrey has made over 49 trades of the Vertex Pharmaceuticals stock since 2004, according to the Form 4 filled with the SEC. This report is not for commercial use. Other Compensation covers all compensation-like awards that don't fit in any of these other standard categories. Median pay numbers ranged from $38,661 to $804,000. Timothy M. Ring. Jeffrey Leiden. $0 was received as non-stock incentive plan compensation,
Leiden, who has also served as … The chart on this page features a breakdown of the total annual pay for Jeffrey M. Leiden at QUEST DIAGNOSTICS INC as reported in their proxy statements. A typical information systems manager salary at The Vertex Companies is $125,881. Jeffrey Leiden Essdras M Suarez/ Globe Staff. Most recently he sold 32,792 units of … Also, proxies must disclose specific detailed information regarding the pay practices for certain executives. The proxy statement's main purpose is to alert shareholders to the annual meeting and provide them information about the issues that will be voted on during the annual meeting, including decisions such as electing directors, ratifying the selection of auditors, and other shareholder-related decisions, including shareholder-initiated initiatives. Rankings In 2018 , Jeffrey M. Leiden's compensation ranked 187th out of 13,814 executives tracked by ExecPay. and Ph.D. from the University of Chicago, where he became Chief of Cardiology. Leiden also received $3.4M in non-equity incentive plan, $4.2M in option awards, $1.3M in salary and $14.7K in other compensation. Of this total $1,300,000 was received as a salary, $3,510,000 was received as a bonus, $4,572,039 was received in stock options, $9,334,681 was awarded as stock and $73,265 came from other types of compensation. The proxy statement includes footnotes and explanations of this information plus other information that is pertinent in assessing the overall value and appropriateness of the compensation information. As a member of Board of Directors at QUEST DIAGNOSTICS INC,
The chart on this page features a breakdown of the total annual pay for Jeffrey M. Leiden, Executive Chairman (CEO and President) at VERTEX PHARMACEUTICALS INC / MA as reported in their proxy statements. As a member of Board of Directors at QUEST DIAGNOSTICS INC , Helen I. Torley made $232,672 in total compensation. President and Chief Executive Officer SAGE THERAPEUTICS INC: Jeffrey M. Keebler Chairman, President, and Chief Executive Officer MGE ENERGY INC: Jeffrey M. Leiden Executive Chairman (CEO and President) VERTEX PHARMACEUTICALS INC / MA: Jeffrey M. Pogol Vice President HIGH SIERRA TECHNOLOGIES, INC. Leiden pulled in $18.8 million, thanks to a hefty bump to his equity-based pay. Jeffrey M. Jonas M.D. ‡ The median salary for workers with 10 or more years of experience per Payscale. Total Cash Compensation information is comprised of yearly Base Pay and Bonuses. You may also find the annual proxy statement by going directly to the company's website. His B.A., M.D. This report is not for commercial use. Stock Awards: Compensation paid in the form of company equity that is structured as restricted stock. Len Schleifer, Regeneron. Terms and Data Sources Get Email Updates. Leiden’s base salary of $1.3 million has … The information shown here is a reporting of information included in the company's proxy statement. and Ph.D. degrees were received from the University of Chicago. $41.97 million. Averaged, that figure rose to just over $7.6 million. She will succeed Jeffrey Leiden, who said he would step down as president and CEO after seven years in those roles. Insulet Corp. – CEO Patrick Sullivan earns $8.2 million in annual pay. Thorough reviews have been conducted to assure this data accurately reflects disclosures. Numbers reported do not include change in pension value and non-qualified deferred compensation earnings. All proxy statements are public filings made available to the general public by the SEC. For its 2019 fiscal year, VERTEX PHARMACEUTICALS INC / MA, listed the following CEO pay ratio data on its annual proxy statement to the SEC. Leiden also received $50K in salary, $3.5M in stock awards and $92.4K in other compensation. This information is according to proxy statements filed for the 2019 fiscal year. Leiden also received $241.8K of change in pension value and nonqualified deferred compensation earnings, $225.1K in salary and $244.1K in other compensation. The proxy must be sent to every shareholder in advance of the company's annual shareholders meeting. Leiden’s 2019 base salary held flat at $1.3 million, while his stock awards fell to $9.33 million and option awards grew to $4.57 million. Change in Pension Value and Nonqualified Deferred Compensation Earnings: The difference between such compensation between the prior year and the current year. He has a B.A., M.D. 1. Jeffrey has made over 49 trades of … The proxy must be sent to every shareholder in advance of the company's annual shareholders meeting. Total Named Director Compensation: The sum of all dollar values above. Jeff Leiden is Chairman at Vertex Pharmaceuticals Inc. See Jeff Leiden's compensation, career history, education, & memberships. In 2015 Vertex shareholders voted to recommend reducing Leiden's compensation from its 2014 estimated figure of US$48.5 million. Rankings In 2006 , Jeffrey M. Leiden's compensation ranked 651st out of 7,022 executives tracked by ExecPay. All proxy statements are public filings made available to the general public by the SEC. Rankings In 2016 , Jeffrey M. Leiden's compensation ranked 170th out of 14,075 executives tracked by ExecPay. Fees Earned or Paid in Cash: This is the amount of fixed retainers and meeting fees and paid in the form of cash. Jeffrey M. Leiden made $56,500 in total compensation. Jeffrey Bewkes, CEO of Time Warner, is the 10th highest-paid CEO, with a 2014 salary of $32.7 million. The proxy statement includes footnotes and explanations of this information plus other information that is pertinent in assessing the overall value and appropriateness of the compensation information. However for a complete and definitive understanding of the pay practices of any company, users should refer directly to the actual, complete proxy statement. Last year, Leiden received $1.1 million in salary as well as $14.9 million in value from a one-time restricted stock grant. Vicky B. Gregg. That's what you want from a CEO. By 2017 his earnings totaled approximately US$17.3 million. Leiden also received $2.2M in non-equity incentive plan, $4.1M in option awards, $1.3M in salary and $12.9K in other compensation. $0 was awarded as stock and
VERTEX PHARMACEUTICALS INC / MA income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. Vertex Pharmaceuticals – Jeff Leiden, CEO of Vertex, receives annual pay of $17.2 million. Jeffrey Leiden, M.D., Ph.D. is the executive chairman of Vertex Pharmaceuticals, a biotechnology company based in Boston, Massachusetts. $0 was received as change in pension value and nonqualified deferred compensation earnings,
Leiden also received $3M in non-equity incentive plan, $12.7M in option awards, $1.1M in salary and $12.9K in other compensation. Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year. $56,500 was received as fees earned or paid in cash,
However, for a complete and definitive understanding of the pay practices of any company, users should refer directly to the actual, complete proxy statement. Show Me. Total Compensation for Fiscal Year Ending in 2019: $18,789,985. A proxy statement (or "proxy") is a form that every publicly traded U.S. company is required to file with the U.S. Securities & Exchange Commission (SEC) within 120 days after the end of its fiscal year. And that's what you want to do as an investor. The top 20 highest-paid biopharma CEOs. The proxy statement's main purpose is to alert shareholders to the annual meeting and provide them information about the issues that will be voted on during the annual meeting, including decisions such as electing directors, ratifying the selection of auditors, and other shareholder-related decisions, including shareholder-initiated initiatives. The median employee pay at Insulet is $94,790, a ratio of 86 to 1. ... “To me, this is really unprecedented innovation,” says Jeffrey Leiden, Vertex’s chief executive. He also received stock awards valued at about $17.6 million. Non-Stock Incentive Plan Compensation: Cash compensation earned for the achievement of predefined objectives. His cash incentive pay … For comparison, the title cashier at The Vertex Companies earns $24,104 per year. That hike slightly outpaced Leiden’s own raise; his $18.8 million pay package represented a 9.1% jump from 2017. 1.